These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6100173)

  • 1. Comparative experimental antibacterial activity of ceftriaxone (Ro 13-9904).
    Böhni E
    Chemioterapia; 1984 Feb; 3(1):25-32. PubMed ID: 6100173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale for clinical trials evaluating ceftriaxone in the therapy of bacterial meningitis.
    Scheld WM; Rocha H; Sande MA; Bryan JP
    Am J Med; 1984 Oct; 77(4C):42-9. PubMed ID: 6093518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ceftriaxone, a long-acting cephalosporin. Microbiological, kinetic and clinical study].
    Soranzo ML; Capra E; Angela GC; Eandi M; Salassa B; Lollini P; Musso E; Pizzo L; Spezia C; Di Nola F
    Minerva Med; 1983 Sep; 74(36):2093-102. PubMed ID: 6312379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term administration of ceftriaxone (Ro 13-9904) to complicated urinary tract infections].
    Oishi K; Kawakita M; Hida S; Higashi Y; Yamauchi T; Yoshida O
    Hinyokika Kiyo; 1985 Apr; 31(4):711-21. PubMed ID: 4036746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
    Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.
    Richards DM; Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1984 Jun; 27(6):469-527. PubMed ID: 6329638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cefotaxime, moxalactam and ceftriaxone: comparison of in vitro activity against hospital strains of Enterobacteriaceae belonging to the 4 principal phenotypes of sensitivity to beta-lactams].
    Jarlier V; Bismuth R; Grosset J
    Pathol Biol (Paris); 1983 May; 31(5):336-42. PubMed ID: 6312393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and bacteriologic efficacy of ceftriaxone in the United States.
    McCloskey RV
    Am J Med; 1984 Oct; 77(4C):97-103. PubMed ID: 6093528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quantitative study of the antibacterial effect of cefotaxime and ceftriaxone during experimental Escherichia coli K1 bacteremia in chickens].
    Labarthe JC; Guillot JF; Mouline C; Bree A
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):664-7. PubMed ID: 2677929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of the therapeutic effect of cephalosporins in experimental endocarditis by altering their pharmacokinetics with diclofenac.
    Joly V; Pangon B; Brion N; Vallois JM; Carbon C
    J Pharmacol Exp Ther; 1988 Aug; 246(2):695-700. PubMed ID: 3042958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftriaxone: therapeutic results in various infections and kinetic studies.
    Giamarellou HJ; Tsagarakis J; Petrikkos G; Mavroudis K; Veldekis D; Daikos GK
    Arzneimittelforschung; 1984; 34(3):321-5. PubMed ID: 6329238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative efficacy of ampicillin, chloramphenicol, cefotaxime, ceftriaxone and pefloxacin in experimental Salmonella typhimurium infection].
    Nauciel C; Martin E
    Pathol Biol (Paris); 1987 Nov; 35(9):1239-42. PubMed ID: 3320900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftriaxone therapy of meningitis and serious infections.
    Steele RW
    Am J Med; 1984 Oct; 77(4C):50-3. PubMed ID: 6093519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of complicated urinary tract infections with the long acting cephalosporin, ceftriaxone.
    Rothwell DL; Bremner DA; Taylor KM
    N Z Med J; 1983 May; 96(732):392-4. PubMed ID: 6302612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of beta-lactams against experimental pneumococcal endocarditis caused by strains with different susceptibilities to penicillin.
    Pichardo C; Docobo-Pérez F; Pachón-Ibáñez ME; Jiménez-Mejías ME; García-Curiel A; Caballero-Granado FJ; Moreno-Maqueda I; Pachón J
    J Antimicrob Chemother; 2005 Oct; 56(4):732-7. PubMed ID: 16150863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of Ertapenem and Ceftriaxone in the eradication of Salmonella in a model of experimental peritonitis in mice.
    Lozano FS; García MI; García E; González B; García MB; García FJ; García JE
    Rev Esp Quimioter; 2009 Sep; 22(3):135-8. PubMed ID: 19662546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The antibacterial activity of ceftriaxone and evaluation criteria for an agar diffusion test with ceftriaxone].
    Grimm H
    Wien Med Wochenschr Suppl; 1985; 87():3-8. PubMed ID: 3856974
    [No Abstract]   [Full Text] [Related]  

  • 19. Single-dose plasma and cerebrospinal fluid pharmacokinetics of ceftriaxone in infants and children.
    Reed MD; Rekate HL; Aronoff SC; Myers CM; Blumer JL
    Clin Pharm; 1983; 2(6):558-63. PubMed ID: 6317277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single daily dose treatment of severe refractory infections with ceftriaxone. Cost savings and possible parenteral outpatient treatment.
    Baumgartner JD; Glauser MP
    Arch Intern Med; 1983 Oct; 143(10):1868-73. PubMed ID: 6312914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.